| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +37,549 | +31% | $0.000000 | 160,351 | 24 Feb 2023 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $678,587 | -2,306 | -1.4% | $294.27 | 158,045 | 24 Feb 2023 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | $5,120,592 | -17,401 | -11% | $294.27 | 140,644 | 24 Feb 2023 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | $5,924,721 | -20,148 | -14% | $294.06 | 120,496 | 27 Feb 2023 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1,697 | 24 Feb 2023 | By 401(k) | F5 | |||||
| holding | CI | Common Stock, $.01 Par Value | 376,643 | 24 Feb 2023 | By GRAT | ||||||
| holding | CI | Common Stock, $.01 Par Value | 90,495 | 24 Feb 2023 | By Trust |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14 , 2022. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |